Domvanalimab
GS-US-699-7184-01
Phase 2 small_molecule active
Quick answer
Domvanalimab for Head and Neck Squamous Cell Carcinoma is a Phase 2 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcus Biosciences
- Indication
- Head and Neck Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active